Infographic. Needle and syringe distribution and opioid agonist treatment coverage in relation to WHO 2020 targets
Description
This resource is part of the European Drug Report 2023, the EMCDDA's annual overview of the drug situation in Europe.
The coverage is based on the latest national estimates of injecting drug use and high-risk opioid use matched by harm reduction activity data (within a maximum of 2 years). The estimate of coverage of opioid agonist treatment for Belgium is derived from a subnational study conducted in 2019.
Source data
The data used to generate infographics and charts on this page may be found below.